Cariprazine

Major

Cariprazine Sotorasib Lumakras Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine St John's Wort Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Sulfinpyrazone Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Tazemetostat Tazverik Explained Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Cariprazine Tecovirimat Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Telaprevir Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Telithromycin Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Telotristat Ethyl Xermelo Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Terbinafine Lamisil Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Thioridazine Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Ticagrelor Brilinta Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Ticlopidine Ticlid® Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Topiramate Eprontia Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Tovorafenib Ojemda Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Troglitazone Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Troleandomycin Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Tucatinib Tukysa Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Upadacitinib Rinvoq Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Vemurafenib Zelboraf Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Verapamil Calan Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Vinblastine Velban® Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Voriconazole Vfend Explained Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Voxelotor Oxbryta Explained Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Zanubrutinib Brukinsa Explained Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Bexarotene Topical Targretin Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Brivaracetam Injection Briviact Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Dexamethasone Injection Decadron Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details Cariprazine Ketoconazole Topical Extina® Foam Increased exposure to cariprazine and its active metabolite, didesmethylcariprazine Details Cariprazine Lenacapavir Injection Sunlenca Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Lenacapavir Oral Sunlenca Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Letermovir Injection Prevymis Increased cariprazine and its major active metabolite (didesmethylcariprazine (DDCAR)) exposure Details Cariprazine Nafcillin Injection Unipen® Injection Effects on the cariprazine exposure has not been evaluated and the net effect is unclear Details

Moderate

Cariprazine Artemether Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Cariprazine Kratom Explained Increased CYP3A substrate exposure Details Cariprazine Mavacamten Camzyos Explained Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Cariprazine Rilzabrutinib Wayrilz Explained Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related adverse reactions Details